Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods Randomized placebo controlled trial; 3 parallel groups.
Unit of randomization: individual.
Participants Dats of data collection: not reported.
Setting: Jersey City Medical Center, New Jersey; predominantly lower socio-economic indigent women Inclusion criteria: women
undergoing primary CS after onset of labor (corresponds to the definition of non-elective)
Exclusion: febrile or infected, allergy to pipericillin.
Interventions Pipericillin 4 g peri-operatively (N = 50) vs pipericillin 4 g peri-operatively and at 4 and 8 hours post-operatively (N = 50) vs placebo (N = 50); both treatment groups combined in analysis
Outcomes Febrile morbidity (> 38.0°C twice at least 6 hours apart after first post-operative day) ; endometritis (fever, tender uterus and purulent lochia); hospital stay (no significant difference, variance not given)
Notes Use of saline or antibiotic lavage not allowed.
No adverse reactions reported with treatment.
Class of antibiotic: ureidopenicillin (pipericillin).
Subgroups:
  • non-elective CS;

  • after cord clamping.

Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear “…randomly divided…”
Allocation concealment? Unclear No information provided.
Blinding? Unclear Described as blinded.
All outcomes
Incomplete outcome data addressed? Unclear No losses or exclusions were reported. The analysis appears to be by ITT
All outcomes
Free of selective reporting? Unclear Insufficient information to judge.
Free of other bias? Unclear The 3 groups were comparable regarding number of vaginal exams, haemoglobin levels and other risk factors. However, there was insufficient information to judge overall
Overall low risk of bias? Unclear Unclear.
HHS Vulnerability Disclosure